Clinical results from MSKCC and many of the other most renowned tertiary care centers are widely known to be unable to ever be reproduced in broader populations, almost certainly because patients at places like MSKCC are disproportionately younger, more fit, have more resources, and have whatever other intangible benefits are conferred by being motivated to travel beyond their local cancer center for very specialized care.
FORBES: Is IBM's Watson in Jeopardy? This Oncologist Thinks So!